American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Avalo Therapeutics, Inc. (AVTX)

$6.93 -6.98% NASDAQ: AVTX · 15-min delayed

WAYNE, Pennsylvania
Public · NASDAQ: AVTX
33 employees

Visit website Follow

$975.5MMarket cap

$59.0KRevenue · FY2025

-$78.3MNet income

33Employees

AVTXNASDAQ

2015IPO

About Avalo Therapeutics, Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: AVTX
Employees: 33
IPO date: Nov 13, 2015
Headquarters: 1500 LIBERTY RIDGE DRIVE
WAYNE, Pennsylvania 19087
Phone: 410-522-8707
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: AVTX Nasdaq
SEC CIK: 1534120
LEI: 549300I1AHR8KMMFIS52
EIN: 450705648
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Avalo Therapeutics, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/avalo-therapeutics-inc/"><img src="https://americancompanies.com/badge/avalo-therapeutics-inc.svg" alt="Avalo Therapeutics, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Avalo Therapeutics, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $59.0K
Net income: -$78.3M
Total assets: $116.5M
Market cap: $975.5M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: AVTX

$6.93 -6.98%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$6.93 $22.87

52-week range

Market cap: $975.5M
Shares outstanding: 140.8M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Nov 13, 2015

Avalo Therapeutics, Inc. (AVTX) Stock Price

Reported a net loss of $78.3M in FY2025.
Trading 70% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Avalo Therapeutics, Inc..

Write a review

Newsroom

News about Avalo Therapeutics, Inc.

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes GlobeNewswire Inc. · 2026-06-26 · positive Avalo Therapeutics Announces Pricing of $375 Million Public Offering GlobeNewswire Inc. · 2026-05-06 · positive Avalo Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. · 2026-02-04 · neutral Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24+ Companies and 26+ Therapies | DelveInsight GlobeNewswire Inc. · 2025-10-23 · positive Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket Benzinga · 2025-09-29 · neutral Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors GlobeNewswire Inc. · 2025-09-22 · positive

News & sentiment via Polygon.io

FAQ

Avalo Therapeutics, Inc.: frequently asked questions

Is Avalo Therapeutics, Inc. an American company?

Avalo Therapeutics, Inc. is a US-based company headquartered in Wayne, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Avalo Therapeutics, Inc. headquartered?

Avalo Therapeutics, Inc. is headquartered in Wayne, Pennsylvania, United States.

Is Avalo Therapeutics, Inc. publicly traded?

Yes — Avalo Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol AVTX on the NASDAQ.

What does Avalo Therapeutics, Inc. do?

Avalo Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore